$9.2M JNJ Stock Sale Planned for September 2026
Johnson & Johnson (JNJ) stock option holder Timothy Schmid plans to sell $9.2 million worth of J&J common stock in September 2026, according to a Form 144 filing.
The sale involves 33,597 shares of JNJ common stock, which were acquired through a stock option exercise with the issuer.
The proposed sale date is September 2, 2026, and Fidelity Brokerage Services LLC will handle the transaction as attorney-in-fact for Schmid.